ACE and cancer: By contrast, there were no significant differences between survivors and non-survivors in gender, body mass index (BMI), smoking status, chest CT severity score, kidney disease, respiratory disease, diabetes, autoimmunity disease, malignancies, use of angiotensin converting enzyme (ACE) inhibitors or angiotensin II receptor blockers (ARBs), monocytes, platelets, red cell distribution width (RDW), and mean platelet volume (MPV).